Article thumbnail

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy

By Apalla Z, Papageorgiou C, Lallas A, Sotiriou E, Lazaridou E, Vakirlis E, Kyrgidis A and Ioannides D

Abstract

Zoe Apalla,1 Chrysoula Papageorgiou,1 Aimilios Lallas,1 Elena Sotiriou,1 Elizabeth Lazaridou,1 Efstratios Vakirlis,1 Athanassios Kyrgidis,2 Demetrios Ioannides1 1First Department of Dermatology, Aristotle University, 2Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Aristotle University, Thessaloniki, Greece Abstract: Vismodegib is approved for the treatment of adult patients with metastatic (mBCC) or locally advanced basal cell carcinoma (laBCC) that have recurred following surgery or for those who are not good candidates for surgery (risk/benefit ratio is against patient’s benefit, either because of the general condition or because of the expected morbidity from the surgery) or radiation therapy. This article provides an evidence-based review of its current place in therapy. Analytically, the clinical implications in the management of laBCCs and mBCCs and possible new indications, including the neoadjuvant use before surgical excision, are discussed, while in the end, the challenges regarding class-related adverse events and their optimal management are highlighted. Keywords: vismodegib, sonic hedgehog inhibitors, basal cell carcinoma, treatment, revie

Topics: vismodegib, sonic hedgehog inhibitors, basal cell carcinoma, treatment, review, Dermatology, RL1-803
Publisher: Dove Medical Press
Year: 2017
DOI identifier: 10.2147/ccid.s101330
OAI identifier: oai:doaj.org/article:d0e6a8310745452ba0b4698a62c74b88
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1178-7015 (external link)
  • https://www.dovepress.com/spot... (external link)
  • https://doaj.org/article/d0e6a... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.